HomeCompareMLCT vs MO

MLCT vs MO: Dividend Comparison 2026

MLCT yields 1025.64% · MO yields 6.27%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 MLCT wins by $23506543.45M in total portfolio value
10 years
MLCT
MLCT
● Live price
1025.64%
Share price
$0.20
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$23506543.53M
Annual income
$19,723,609,349,823.79
Full MLCT calculator →
MO
Altria Group Inc.
● Live price
6.27%
Share price
$67.02
Annual div
$4.20
5Y div CAGR
22.6%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$77.7K
Annual income
$28,968.54
Full MO calculator →

Portfolio growth — MLCT vs MO

📍 MLCT pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodMLCTMO
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, MLCT + MO cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
MLCT pays
MO pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

MLCT
Annual income on $10K today (after 15% tax)
$87,179.49/yr
After 10yr DRIP, annual income (after tax)
$16,765,067,947,350.22/yr
MO
Annual income on $10K today (after 15% tax)
$532.68/yr
After 10yr DRIP, annual income (after tax)
$24,623.26/yr
At 15% tax rate, MLCT beats the other by $16,765,067,922,726.96/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of MLCT + MO for your $10,000?

MLCT: 50%MO: 50%
100% MO50/50100% MLCT
Portfolio after 10yr
$11753271.80M
Annual income
$9,861,804,689,396.17/yr
Blended yield
83.91%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MO right now

MLCT
No analyst data
Altman Z
-1.8
Piotroski
2/9
MO
Analyst Ratings
16
Buy
9
Hold
1
Sell
Consensus: Buy
Price Target
$61.25
-8.6% upside vs current
Range: $47.00 — $68.00
Altman Z
3.2
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

MLCT buys
0
MO buys
0
No recent congressional trades found for MLCT or MO in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricMLCTMO
Forward yield1025.64%6.27%
Annual dividend / share$2.00$4.20
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%22.6%
Portfolio after 10y$23506543.53M$77.7K
Annual income after 10y$19,723,609,349,823.79$28,968.54
Total dividends collected$23218513.75M$72.0K
Payment frequencyquarterlyquarterly
SectorStockConsumer Staples

Year-by-year: MLCT vs MO ($10,000, DRIP)

YearMLCT PortfolioMLCT Income/yrMO PortfolioMO Income/yrGap
1← crossover$113,264$102,564.10$10,558$768.31+$102.7KMLCT
2$1,206,878$1,085,685.14$11,352$1,015.87+$1.20MMLCT
3$12,102,987$10,811,628.23$12,482$1,367.86+$12.09MMLCT
4$114,279,868$101,329,670.98$14,103$1,883.39+$114.27MMLCT
5$1,016,469,856$894,190,397.43$16,472$2,664.91+$1016.45MMLCT
6$8,520,740,273$7,433,117,527.67$20,024$3,897.79+$8520.72MMLCT
7$67,350,310,269$58,233,118,176.66$25,537$5,933.74+$67350.28MMLCT
8$502,243,173,894$430,178,341,906.41$34,478$9,476.77+$502243.14MMLCT
9$3,535,452,502,858$2,998,052,306,790.74$49,776$16,022.63+$3535452.45MMLCT
10$23,506,543,527,881$19,723,609,349,823.79$77,699$28,968.54+$23506543.45MMLCT

MLCT vs MO: Complete Analysis 2026

MLCTStock

Malachite Innovations, Inc., together with its subsidiaries, provides health and wellness products in the United States. It offers a portfolio of approximately 100 novel cannabosides, including glycosylated tetrahydrocannabinol, cannabidiol, cannabidivarin, and cannabinol. The company also develops THC-glycoside (VBX-100), an oral prodrug for the treatment of gastrointestinal diseases, including inflammatory bowel disease and irritable bowel syndrome. In addition, it engages in identifying, investing in, and repositioning environmental situations with a focus on technological innovations and eco-friendly solutions. The company was formerly known as Vitality Biopharma, Inc. and changed its name to Malachite Innovations, Inc. in October 2021. Malachite Innovations, Inc. was incorporated in 2007 and is headquartered in Cleveland, Ohio.

Full MLCT Calculator →

MOConsumer Staples

Altria Group, Inc., through its subsidiaries, manufactures and sells smokeable and oral tobacco products in the United States. The company provides cigarettes primarily under the Marlboro brand; cigars and pipe tobacco principally under the Black & Mild brand; and moist smokeless tobacco products under the Copenhagen, Skoal, Red Seal, and Husky brands, as well as provides on! oral nicotine pouches. It sells its tobacco products primarily to wholesalers, including distributors; and large retail organizations, such as chain stores. Altria Group, Inc. was founded in 1822 and is headquartered in Richmond, Virginia.

Full MO Calculator →
📬

Get this MLCT vs MO comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

MLCT vs SCHDMLCT vs JEPIMLCT vs OMLCT vs KOMLCT vs MAINMLCT vs PMMLCT vs BTIMLCT vs PG

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.